NEW YORK, July 15 -Diagnostics startup HandyLab said today it has been awarded a $2 million ATP grant from the US National Institute of Standards and Technology to develop its portable DNA analysis device
The system under development uses microfluidics and electrochemical detection technologies, and is designed to process raw clinical and environmental samples. The system is being developed to perform PCR, RT-PCR, nucleic acid testing and bioassays for biodefense and for clinical diagnostics in hospital settings.
The Ann Arbor, Mich.-based company is attempting to develop this system as a low-cost and portable alternative to current options in field and point-of-care DNA, protein, and other clinical testing.
For a more in-depth view of HandyLab, see the October 2002 Genome Technology story.